Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Clinical focus: Lung cancer

Lung cancer

Articles (Lung cancer)

Diagnosis and staging of disease
Early detection of lung cancer can improve treatment outcomes. Pharmacists should take an active role in raising people’s awareness of lung cancer signs and symptoms and ensure prompt referral to GPs
PDF (820K)

Treatment
First-line treatment for non-small cell lung cancer is surgery; but many patients are not suitable and, for these patients, management may involve radiotherapy, chemotherapy or newer targeted therapies 
PDF (940K)

Questions

April 2011’s questions are based on the CLINICAL FOCUS articles on Lung cancer, which were commissioned from independent authors.

The information below helps you to identify knowledge gaps and undertake continuing professional development.

The questions can be

  • viewed/printed as a PDF (40K)

This online module will close on 28 June 2011

Lifelong LearningAnswers

When you have completed the module your answers will be submitted for marking and Clinical Pharmacist will send you a certificate and your results by email within two weeks of the module closing.

We have designed the online Lifelong Learning modules to be as user-friendly as possible. Please contact us if you have any technical problems with the module. Your feedback would also be appreciated.

Email: clinicalpharmacist@pharmj.org.uk

How to undertake continuing professional development

Reflect on your gaps in knowledge

  • What symptoms are suggestive of lung cancer?
  • What targeted therapies are available for the treatment of advanced non-small cell lung cancer?
  • What kind of monitoring is required for patients undergoing treatment for lung cancer?

Act to enhance your practice

  • Read the CLINICAL FOCUS articles in this issue (pp106-114)

Evaluate

  • What have you learnt?
  • How has it added to the value of your practice?
  • What will you do now and how will this be achieved?

The questions on Lung cancer have been approved by the Royal Pharmaceutical Society using an independent reviewer as a resource to support your professional development.

Consider making this activity one of your nine CPD entries this year.

Citation: Clinical Pharmacist URI: 11072150

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary information

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.